Diamyd Medical
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.
Market cap
$165m
Enterprise value
$151m
Share price
SEK9.47 DMYD-B.ST
Company register number
556242-3797
loading funding rounds…
Innovation Works(exited)
JDRF(exited)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (30 %) | 112 % | (74 %) | (26 %) | 79 % | 20 % | (76 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (6047 %) | (2323 %) | 3046 % | (32860 %) | (23246 %) | (20367 %) | (97154 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (6054 %) | (2335 %) | 2847 % | 23734 % | (22802 %) | (21259 %) | (116811 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 4011 % | 1426 % | 4050 % | 22475 % | 16645 % | 12804 % | 74221 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.